FDA panel backs previously rejected obesity pill

Qnexa from drug company Vivus, has been previously rejected by the FDA.

However, new support from studies has changed the minds of health advisers.

A panel voted 20 - 0 in favor of Qnexa this time, citing "impressive weight loss results".


Feb 22, 6:33 PM EST -- AP

But the group stressed that the drugmaker must be required to conduct a large, follow-up study of the pill's effects on the heart. Studies of Qnexa show it raises heart rate and causes heart palpitations, a longtime concern with diet pills over the years. The group of experts said it is still unclear if those side effects lead to heart attack and more serious cardiovascular problems.

"The potential benefits of this medication seem to trump the side effects, but in truth, only time will tell," said Dr. Kenneth Burman of the Washington Hospital Center.

The FDA is not required to follow the advice of its panels, though it often does. A final decision on the drug is expected by mid-April.

Details in the links
Story from AP


Vivus has some information:
Vivus explanation


The question as always is:

Do the benefits/results outweigh the dangers ? (no pun intended !)

ya
13 years..blah.

I would venture to say the benefits far outweigh the negative aspects.

But mostly if the pill is used only temporary and then stopped once prime weight is hit...then its all about retraining yourself to eat right and exercise...not treat weight like a chronic illness.